Table 1
Statistical analysis of union index
| Group Day | 15 | 30 | 45 |
|---|---|---|---|
| Control | 0.2 ± 0.447 | 1 ± 0.707 | 2 ± 0.707 |
| Hydroxyapatite | 0.8 ± 0.836 | 2 ± 0.707 | 2.6 ± 0.894 |
| β-tricalcium phosphate | 1 ± 0.707 | 2.6 ± 1.14 | 3.4 ± 0.894 |
| Nanocomposite polycaprolactone | 1.8 ± 0.836 | 3.4 ± 0.547 | 3.8 ± 0.447 |
Table 2
Average union indices
| Group | number | Average score | Test statistics | df | Sig |
|---|---|---|---|---|---|
| 5 | 4 | ||||
| Control | 5 | 7.9 | 9.009 | 2 | 0.011 |
| 5 | 12.1 | ||||
| 5 | 4.1 | ||||
| Hydroxyapatite | 5 | 8.6 | 7.138 | 2 | 0.028 |
| 5 | 11.3 | ||||
| 5 | 3.7 | ||||
| β-tricalcium | |||||
| 5 | 8.8 | 8.258 | 2 | 0.016 | |
| phosphate | |||||
| 5 | 11.5 | ||||
| 5 | 3.4 | ||||
| Nanocomposite | |||||
| 9.508 | 2 | 0.009 | |||
| polycaprolactone | 5 | 9.2 | |||
| 5 | 11.4 |
Table 3
Statistical analysis of spongiosa index
| Group Day | 15 | 30 | 45 |
|---|---|---|---|
| Control | 0.2 ± 0.447 | 0.8 ± 0.836 | 2 ± 0.707 |
| Hydroxyapatite | 0.6 ± 0.547 | 1.2 ± 0.447 | 2.8 ± 0.836 |
| β-tricalcium phosphate | 1 ± 0.707 | 2.2 ± 0.447 | 3.2 ± 0.447 |
| Nanocomposite polycaprolactone | 1.4 ± 0.547 | 3 ± 1 | 3.8 ± 0.447 |
Table 4
Average spongiosa indices
| Group | number | Average score | Test statistics | df | Sig |
|---|---|---|---|---|---|
| 5 | 4.5 | ||||
| Control | 5 | 7.3 | 8.422 | 2 | 0.015 |
| 5 | 12.2 | ||||
| 5 | 4.2 | ||||
| Hydroxyapatite | 5 | 7 | 10.818 | 2 | 0.004 |
| 5 | 12.8 | ||||
| 5 | 3.4 | ||||
| β-tricalcium phosphate | 5 | 8 | 11.482 | 2 | 0.003 |
| 5 | 12.6 | ||||
| 5 | 3.4 | ||||
| Nanocomposite | 5 | 8.9 | 9.789 | 2 | 0.007 |
| polycaprolactone | 5 | 11.7 |
Table 5
Statistical analysis of cortex index
| Group Day | 15 | 30 | 45 |
|---|---|---|---|
| Control | 0.2 ± 0.447 | 1 ± 0.707 | 1.8 ± 0.447 |
| Hydroxyapatite | 0.6 ± 0.547 | 1.4 ± 0.547 | 2.2 ± 0.836 |
| β-tricalcium phosphate | 1.4 ± 0.547 | 2 ± 0.707 | 3.2 ± 0.836 |
| Nanocomposite polycaprolactone | 1.8 ± 0.836 | 2.8 ± 0.836 | 3.6 ± 0.547 |
Table 6
Average cortex indices
| Group | number | Average score | Test statistics | df | Sig |
|---|---|---|---|---|---|
| 5 | 4 | ||||
| Control | 5 | 8 | 8.96 | 2 | 0.011 |
| 5 | 12 | ||||
| 5 | 5 | ||||
| Hydroxyapatite | 5 | 6.9 | 7.808 | 2 | 0.02 |
| 5 | 12.1 | ||||
| 5 | 4.2 | ||||
| β-tricalcium phosphate | 5 | 8.2 | 8.076 | 2 | 0.018 |
| 5 | 11.6 | ||||
| 5 | 4.2 | ||||
| Nanocomposite | 7.591 | 2 | 0.022 | ||
| polycaprolactone | 5 | 8.1 | |||
| 5 | 11.7 |
Table 7
Statistical analysis of bone marrow index
| Day | |||
|---|---|---|---|
| Group | 15 | 30 | 45 |
| Control | 0.2 ± 0.447 | 1 ± 0.707 | 1.4 ± 0.547 |
| Hydroxyapatite | 1 ± 0.707 | 1.4 ± 0.547 | 2.4 ± 0.547 |
| β-tricalcium phosphate | 1.4 ± 0.547 | 1.8 ± 0.836 | 2.8 ± 0.447 |
| Nanocomposite polycaprolactone | 1.6 ± 0.547 | 2.4 ± 0.547 | 3.4 ± 0.547 |
Table 8
Average bone marrow indices
| Groups | number | Average scores | Test statistics | df | Sig |
|---|---|---|---|---|---|
| 5 | 4.20 | ||||
| Control | 5 | 8.80 | 7.023 | 2 | 0.030 |
| 5 | 11 | ||||
| 5 | 5 | ||||
| Hydroxyapatite | 5 | 6.90 | 7.736 | 2 | 0.021 |
| 5 | 12.10 | ||||
| 5 | 5 | ||||
| β-tricalcium phosphate | 5 | 7 | 7.280 | 2 | 0.26 |
| 5 | 12 | ||||
| 5 | 3.90 | ||||
| Nanocomposite | 5 | 7.70 | 10.092 | 2 | 0.006 |
| polycaprolactone | |||||
| 5 | 12.40 |

Fig. 1
Microscopic view of healing area in control group on day 15. It shows abundant capillary buds (arrows) in granulation tissue (H&E, 100×)

Fig. 2
Microscopic view of healing area in tricalcium phosphate (TCP) group on day 15. It shows abundant calcified cartilage (arrow) (H&E, 100×)

Fig. 3
Microscopic view of healing area in hydroxyapatite (HA) group on day 15.It shows fibrous tissue (arrow) (H&E, 100×)

Fig. 4
Microscopic view of healing area in PCL group on day 15. It shows primary bone (arrows) formation (H&E, 100×)

Fig. 5
Microscopic view of healing area in control group on day 30. It shows abundant fibrous tissue (arrows) filling marrow space (H&E, 100×)

Fig. 6
Microscopic view of healing area in tricalcium phosphate (TCP) group on day 30. Primary bones (arrow) are being produced (H&E, 100×)

Fig. 7
Microscopic view of healing area in hydroxyapatite group on day 30. Calcified cartilage (arrow) in the mature granulation tissue (H&E, 100×)

Fig. 8
Microscopic view of healing area in PCL group on day 30. Woven bones (arrows) are being produced (H&E, 100×)

Fig. 9
Microscopic view of healing area in control group on day 45. Bone deposition within cartilage (star) at healing site shows primary (arrows) ossification (H&E, 100×)

Fig. 10
Microscopic view of healing area in tricalcium phosphate (TCP) group on day 45. Lamellar bone formation (arrows) in healing site is shown (H&E, 100×)

Fig. 11
Microscopic view of healing area in hydroxyapatite group on day 45. The defect is filled with primary bone (arrows) and well-formed marrow (star) (H&E, 100×)

Fig. 12
Microscopic view of healing area in PCL group on day 45. The defect is filled with lamellar (arrows) bone (H&E, 100×)